Volume 12, Number 10—October 2006
Chikungunya Virus Strains, Reunion Island Outbreak
To the Editor: Chikungunya virus (CHIKV) is endemic in rural tropical Africa and is penetrating urban areas in Asia. CHIKV is maintained in a sylvatic cycle that involves mosquitoes of the genus Aedes, primates, and rodents. CHIKV infection induces fever, arthralgia, and maculopapular rash. Hemorrhagic complications have been reported in some outbreaks, but a more specific symptom is severe arthralgia, often persistent, which results in long-lasting disability.
After numerous cases of CHIKV infection had been reported in Comoros and Mauritius (1), an outbreak of febrile illness was reported on Reunion Island in March 2005 (2). The incidence of the disease remained relatively low until December 2005, when it increased dramatically. The outbreak resulted in >3,500 confirmed cases and an estimated 250,000 suspected cases (2), affecting >25% of the island's inhabitants. Encephalitic forms were reported on many occasions during the active phase of the outbreak, and >200 persons died while they were infected with CHIKV. Previously unreported complications, such as mother-to-child transmission, myocarditis, hepatitis, and extensive dermal lesions were also encountered.
Many samples, collected from patients during the outbreak, were sent to our laboratory (Virology Unit, Tropical Institute of the French Armed Forces Medical Service, Marseille, France) to identify the etiologic agent. Serum samples incubated with C6/36 cells according to previously published methods (3) yielded CHIKV. This virus was also isolated from cerebrospinal fluid collected from a patient with encephalitis, from corneas collected from asymptomatic human organ donors, and from pools of mosquitoes (Aedes albopictus and Culex quinquefasciatus) collected on the island.
Five isolates were partially sequenced. The CHIKV genome was partly amplified by using the specific primer pair OP16/OP17 (4), and reverse transcription (RT)-PCR products (1,200 nucleotides long) were cloned and sequenced (GenBank accession nos. DQ462746–DQ462750). Comparison of partial sequences showed a high degree of identity between the strains isolated in Reunion, including the strain LR2006_OPY1 (5): paired identity was 99.3%–100% at the nucleotide level and 98.2%–100% at the amino acid level. The nucleotide and amino acid substitutions were homogeneously distributed across the sequence and were different for each isolate. Our strain IMT/6470, isolated from human serum, and the strain LR2006_OPY1 displayed the same nucleotide sequence in the sequenced region. The sequence identity among these isolates highlights the common origin of human and mosquito isolates.
The sequences of our isolates did not feature any codon deletions or insertions when compared with other CHIKV isolates from Africa and Asia available in GenBank (4,6). Strains from Reunion were also compared with the candidate vaccine strain TSI-GSD-218 (7). This strain showed 93%–94% and 96%–97% identity at the nucleotide and amino acid level, respectively, which suggests a sufficient antigenic community. Nevertheless, cross-neutralization experiments are necessary to confirm the protective effect of this candidate vaccine against Reunion strains.
In the phylogenetic tree based on the partial E1 sequences (Figure), all CHIKV strains isolated in Reunion clustered together. These strains were closely related to strains from the Central African Republic and the Democratic Republic of Congo (4,6). This finding suggests that the boundaries of the Central African CHIKV strains now extend to the Indian Ocean. The phylogenetic tree also illustrates the difference of lineage between the Reunion Island isolates and the Asian isolates.
CHIKV has been isolated from Culex spp. collected during outbreaks (8), but laboratory experiments have shown that Cx. quinquefasciatus failed to transmit CHIKV to monkeys (9). Inside the Reunion cluster, the strain from Culex spp. was localized in a separate branch (bootstrap value 100%); this finding could be relevant to the different role of these mosquito species in virus epidemiology.
To our knowledge, CHIKV has never been isolated from human corneas. In our study, the cornea sample was obtained from an asymptomatic donor whose serum contained immunoglobulin M (IgM) but not IgG to CHIKV; this finding suggests the patient was recently infected with CHIKV. The presence of CHIKV in corneal cells will have to be confirmed because the samples we studied also included sclera, vascular tissue that could contain circulating virions; however, no virus was detected in the patient's blood sample by CHIKV-specific RT-PCR assay (10). Infected corneal or scleral cells may constitute a sanctuary that allows virus to persist after virus is no longer present in blood. Because viral persistence, which could explain long-lasting clinical complications of CHIKV infection, has never been demonstrated, this question deserves more investigation.
Our results indicate that CHIKV strains responsible for the outbreak in Reunion have a common origin and do not differ from strains circulating in East and Central Africa. More complete characterization of the 5 strains we report here, sequencing of the full-length genome, and phenotypic characterization of other CHIKV isolated in the area during the same period is currently underway in our laboratory.
We are indebted to Jean-Marie Milleliri for advice; Jon M. Davis for reviewing the paper; and Patrick Gravier, Christophe N'Guyen, and Yannick Sanson for excellent technical assistance.
- World Health Organization. Chikungunya in La Reunion Island (France) 2006 Feb 17 [cited 2006 Aug 1]. Available from http://www.who.int/csr/don/2006_02_17a/en/
- La Réunion-Mayotte CIRE. Epidémie de chikungunya à la Réunion. Point hebdomadaire, semaine 13. 2006 Apr 6 [cited 2006 Aug 7]. Available from http://www.invs.sante.fr/presse/2006/le_point_sur/chikungunya_reunion_070406/chikungunya_s13.pdf
- Peyrefitte CN, Pastorino BAM, Bessaud M, Gravier P, Tock F, Couissinier-Paris P, Dengue type 3 virus, Saint Martin, 2003–2004. Emerg Infect Dis. 2005;11:757–61.
- Pastorino B, Muyembe-Tamfum JJ, Bessaud M, Tock F, Tolou H, Durand JP, Epidemic resurgence of chikungunya virus in Democratic Republic of the Congo: identification of a new Central African strain. J Med Virol. 2004;74:277–82.
- Charrel R, Lamballerie X. Reunion sequence. ProMed. 2006 Mar 23. Available from http://www.promedmail.org, archive no. 20060323.0896.
- Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol. 2000;81:471–9.
- Edelman R, Tacket CO, Wasserman SS, Bodinson SA, Perry JG, Mangiafico JA. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62:681–5.
- Vaucel M. Affections dues aux virus: chapitre VII. Affections à virus neurotropes. In: Médecine tropicale. Paris: Editions Médicales Flammarion; 1966. p. 1111–7.
- Jupp PG, McIntosh BM, dos Santos I, DeMoor P. Laboratory vector studies on six mosquito and one tick species with chikungunya virus. Trans R Soc Trop Med Hyg. 1981;75:15–9.
- Pastorino B, Bessaud M, Grandadam M, Murri S, Tolou HJ, Peyrefitte CN. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African chikungunya viruses. J Virol Methods. 2005;124:65–71.
Suggested citation for this article: Bessaud M, Peyrefitte CN, Pastorino BAM, Tock F, Merle O, Colpart JJ, et al. Chikungunya virus strains, Reunion Island outbreak [letter]. Emerg Infect Dis [serial on the Internet]. 2006 Oct [date cited]. http://dx.doi.org/10.3201/eid1210.060596
- Page created: November 10, 2011
- Page last updated: November 10, 2011
- Page last reviewed: November 10, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)